Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

On launching the new OPEN ARMS PPI group in Oxford, Dr. Laura Coates explored the patient and public involvement (PPI) models of three academic centres in the UK to show how it benefits researchers, clinicians, and patients alike.

Laura Coates

It has been shown beyond doubt that involving patients and the public in research provides long term benefits, promoting higher standards of research and improved patient outcomes. Patient participation, and patient engagement are important facets of patient-centred research. Patient involvement (PPI), as defined by INVOLVE, a national advisory group funded by the National Institute for Health Research (NIHR), is 'research being carried out 'with' or 'by' members of the public rather than 'to'.

It's this involvement that has positively influenced the research process; from the initial stages of research with the development of research questions, research design and delivery, data collection and analysis, through to dissemination.

PPI is particularly crucial in rheumatology research, as most rheumatic and musculoskeletal conditions are life-long and life-altering. So how should PPI be undertaken to ensure consistency, quality, and represent patients from a range of demographics to ensure that the research represents the wider community?

In 2020, the Oxford Patient Engagement Network in Arthritis and Musculoskeletal Science (OPEN ARMS) group was launched at NDORMS. Leading the launch, Dr Laura Coates drew on the experience of other established groups in the UK.

NIHR Leeds Biomedical Research Centre

The NIHR Leeds Biomedical Research Centre has over 250 people comprising patients, carers, and members of the public. Alongside bi-monthly meetings, task and finish working groups, the group supports activities to involve under-represented groups and promote diversity within its patient community.

University College London (UCL)

UCL has developed a model of a core patient and public involvement cohort representing various rheumatic conditions who will provide input during virtual meetings, with discussion around research project development and priority setting. Patient-facing literature and other research documentation is written in language that is understandable to the general public.

Oxford Biomedical Research Centre

The Oxford Biomedical Research Centre runs a large and successful advisory group overseeing patient and public involvement across all specialities. OPEN ARMS launched within the musculoskeletal theme aiming to focus on diversity and gain representation from previously harder to reach groups through carefully designed recruitment materials and extensive outreach to different community groups.

The groups faced different challenges through the Covid pandemic. The move to virtual platforms may have had an adverse impact on participation from under-represented groups with lower technology proficiency. For others, online meetings may have appealed to the younger demographics.

The challenge will be to adapt activities to remain inclusive to all patient communities while continuing to apply innovative thinking to develop dynamic, impactful collaborations with patients that also benefit researchers and clinicians.

Read the full paper here.

Similar stories

Emergency to use the FORCE pathway for wrist fractures in children

New research from the University of Oxford has shown that doctors can simplify treatment for the most common fracture in children, reducing NHS costs.

Kennedy researchers awarded funding to improve the understanding of inflammatory bowel diseases

A new £1.5M grant from the Medical Research Council (MRC) to the Powrie Group at the Kennedy Institute will help define different pathotypes of inflammatory bowel diseases that could lead to better and more focused treatments for patients.

Yoshi Itoh wins the International Dupuytren Award 2022

Yoshi Itoh, Associate Professor and Principal Investigator Cell Migration Group at the Kennedy Institute has been awarded the International Dupuytren Award 2022.

Taking a break from immune-suppressing medicines doubles the antibody response to COVID-19 booster vaccination

The Oxford Clinical Trials Research Unit (OCTRU) at NDORMS played a key role in the VROOM study which found that pausing immune-suppressing medicines such as methotrexate can increase the response to COVID-19 booster jabs.

Ten Years of Athena Swan in the Medical Sciences Division

2022 marks ten years since the first Athena Swan Bronze applications from the Medical Sciences Division. Ten years later, and all 16 departments in the Division have achieved a Silver Award. We look at NDORMS’ Athena Swan journey.

NDORMS researchers awarded Associate Professor title

The University of Oxford has awarded the title of Associate Professor to Adam Cribbs and Luke Jostins.